Seeking men and women who have received cellular therapy in the past year and are now receiving the COVID-19 vaccine as a part of their standard of care.
We are studying how well the vaccine for Covid-19 works in individuals who have been previously treated with transplant or CAR-T cell therapy. Participants will provide blood specimens at 4 timepoints over the course of approximately 7 months.
What we're hoping for
We hope to learn whether or not individuals who have been treated with transplant have the same level of protection from the covid-19 vaccine compared to those who have not undergone transplant.
ClinicalTrials.gov Identifier: Not Available